1
|
Sakurai K, Dainichi T, Garcet S, Tsuchiya
S, Yamamoto Y, Kitoh A, Honda T, Nomura T, Egawa G, Otsuka A, et
al: Cutaneous p38 mitogen-activated protein kinase activation
triggers psoriatic dermatitis. J Allergy Clin Immunol.
144:1036–1049. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Mai L, Zhu X, Huang F, He H and Fan W: p38
mitogen-activated protein kinase and pain. Life Sci.
256:1178852020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zarubin T and Han J: Activation and
signaling of the p38 MAP kinase pathway. Cell Res. 15:11–18. 2005.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Coulthard LR, White DE, Jones DL,
Mcdermott MF and Burchill SA: p38(MAPK): Stress responses from
molecular mechanisms to therapeutics. Trends Mol Med. 15:369–379.
2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Uchida S, Yoshioka K, Kizu R, Nakagama H,
Matsunaga T, Ishizaka Y, Poon RY and Yamashita K: Stress-activated
mitogen-activated protein kinases c-Jun NH2-terminal kinase and p38
target Cdc25B for degradation. Cancer Res. 69:6438–6444. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Garcia-Hernandez L, Garcia-Ortega MB,
Ruiz-Alcala G, Carrillo E, Marchal JA and Garcia MA: The p38 MAPK
components and modulators as biomarkers and molecular targets in
cancer. Int J Mol Sci. 23:3702021. View Article : Google Scholar : PubMed/NCBI
|
8
|
Peluso I, Yarla NS, Ambra R, Pastore G and
Perry G: MAPK signalling pathway in cancers: Olive products as
cancer preventive and therapeutic agents. Semin Cancer Biol.
56:185–195. 2019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Messina S, Frati L, Leonetti C, Zuchegna
C, Di Zazzo E, Calogero A and Porcellini A: Dual-specificity
phosphatase DUSP6 has tumor-promoting properties in human
glioblastomas. Oncogene. 30:3813–3820. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Luan Q, Jin L, Jiang C, Tay KH, Lai F, Liu
XY, Liu YL, Guo ST, Li CY, Yan XG, et al: RIPK1 regulates survival
of human melanoma cells upon endoplasmic reticulum stress through
autophagy. Autophagy. 11:975–994. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cheng G, Fan X, Hao M, Wang J, Zhou X and
Sun X: Higher levels of TIMP-1 expression are associated with a
poor prognosis in triple-negative breast cancer. Mol Cancer.
15:302016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Qi X, Yin N, Ma S, Lepp A, Tang J, Jing W,
Johnson B, Dwinell MB, Chitambar CR and Chen G: p38gamma MAPK is a
therapeutic target for triple-negative breast cancer by stimulation
of cancer stem-like cell expansion. Stem Cells. 33:2738–2747. 2015.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen XF, Pan YS, Zheng B and Lu Q:
p38gamma overexpression promotes renal cell carcinoma cell growth,
proliferation and migration. Biochem Biophys Res Commun.
516:466–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang D, Wang Y, Zou X, Shi Y, Liu Q, Huyan
T, Su J, Wang Q, Zhang F, Li X and Tie L: FOXO1 inhibition prevents
renal ischemia-reperfusion injury via cAMP-response element binding
protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis. Br
J Pharmacol. 177:432–448. 2020. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He
Y, Lun Y and Zhang J: Immune cell confrontation in the papillary
thyroid carcinoma microenvironment. Front Endocrinol (Lausanne).
11:5706042020. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yu X, Zhong P, Han Y, Huang Q, Wang J, Jia
C and Lv Z: Key candidate genes associated with BRAF(V600E) in
papillary thyroid carcinoma on microarray analysis. J Cell Physiol.
234:23369–23378. 2019. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pan Z, Li L, Fang Q, Qian Y, Zhang Y, Zhu
J, Ge M and Huang P: Integrated bioinformatics analysis of master
regulators in anaplastic thyroid carcinoma. Biomed Res Int.
2019:97345762019. View Article : Google Scholar : PubMed/NCBI
|
18
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
21
|
The Gene Ontology Consortium, . The Gene
Ontology Resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kanehisa M: A database for post-genome
analysis. Trends Genet. 13:375–376. 1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Koch A, De Meyer T, Jeschke J and Van
Criekinge W: MEXPRESS: Visualizing expression, DNA methylation and
clinical TCGA data. BMC Genomics. 16:6362015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Hou S, Suresh PS, Qi X, Lepp A, Mirza SP
and Chen G: p38γ Mitogen-activated protein kinase signals through
phosphorylating its phosphatase PTPH1 in regulating ras protein
oncogenesis and stress response. J Biol Chem. 287:27895–27905.
2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xu Y, Sun Q, Yuan F, Dong H, Zhang H, Geng
R, Qi Y, Xiong X, Chen Q and Liu B: RND2 attenuates apoptosis and
autophagy in glioblastoma cells by targeting the p38 MAPK
signalling pathway. J Exp Clin Cancer Res. 39:1742020. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kiaie SH, Sanaei MJ, Heshmati M, Asadzadeh
Z, Azimi I, Hadidi S, Jafari R and Baradaran B: Immune checkpoints
in targeted-immunotherapy of pancreatic cancer: New hope for
clinical development. Acta Pharm Sin B. 11:1083–1097. 2021.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Wei C, Wang B, Peng D, Zhang X, Li Z, Luo
L, He Y, Liang H, Du X, Li S, et al: Pan-cancer analysis shows that
ALKBH5 is a potential prognostic and immunotherapeutic biomarker
for multiple cancer types including gliomas. Front Immunol.
13:8495922022. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bonaventura P, Shekarian T, Alcazer V,
Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C and
Depil S: Cold tumors: A therapeutic challenge for immunotherapy.
Front Immunol. 10:1682019. View Article : Google Scholar : PubMed/NCBI
|
30
|
Picard E, Verschoor CP, Ma GW and Pawelec
G: Relationships between immune landscapes, genetic subtypes and
responses to immunotherapy in colorectal cancer. Front Immunol.
11:3692020. View Article : Google Scholar : PubMed/NCBI
|
31
|
Goodman AM, Sokol ES, Frampton GM, Lippman
SM and Kurzrock R: Microsatellite-stable tumors with high
mutational burden benefit from immunotherapy. Cancer Immunol Res.
7:1570–1573. 2019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Koch A, Joosten SC, Feng Z, de Ruijter TC,
Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, et
al: Analysis of DNA methylation in cancer: Location revisited. Nat
Rev Clin Oncol. 15:459–466. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
34
|
Rouse J, Cohen P, Trigon S, Morange M,
Alonso-Llamazares A, Zamanillo D, Hunt T and Nebreda AR: A novel
kinase cascade triggered by stress and heat shock that stimulates
MAPKAP kinase-2 and phosphorylation of the small heat shock
proteins. Cell. 78:1027–1037. 1994. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lechner C, Zahalka MA, Giot JF, Møller NP
and Ullrich A: ERK6, a mitogen-activated protein kinase involved in
C2C12 myoblast differentiation. Proc Natl Acad Sci USA.
93:4355–4359. 1996. View Article : Google Scholar : PubMed/NCBI
|
36
|
Li Z, Jiang Y, Ulevitch RJ and Han J: The
primary structure of p38 gamma: A new member of p38 group of MAP
kinases. Biochem Biophys Res Commun. 228:334–340. 1996. View Article : Google Scholar : PubMed/NCBI
|
37
|
Jiang Y, Gram H, Zhao M, New L, Gu J, Feng
L, Di Padova F, Ulevitch RJ and Han J: Characterization of the
structure and function of the fourth member of p38 group
mitogen-activated protein kinases, p38delta. J Biol Chem.
272:30122–30128. 1997. View Article : Google Scholar : PubMed/NCBI
|
38
|
Xu W, Liu R, Dai Y, Hong S, Dong H and
Wang H: The role of p38gamma in cancer: From review to outlook. Int
J Biol Sci. 17:4036–4046. 2021. View Article : Google Scholar : PubMed/NCBI
|
39
|
Lin J, Yang J, Xu X, Wang Y, Yu M and Zhu
Y: A robust 11-genes prognostic model can predict overall survival
in bladder cancer patients based on five cohorts. Cancer Cell Int.
20:4022020. View Article : Google Scholar : PubMed/NCBI
|
40
|
Roche O, Fernandez-Aroca DM,
Arconada-Luque E, Garcia-Flores N, Mellor LF, Ruiz-Hidalgo MJ and
Sanchez-Prieto R: p38beta and cancer: The beginning of the road.
Int J Mol Sci. 21:75242020. View Article : Google Scholar : PubMed/NCBI
|
41
|
Yang K, Liu Y, Liu Z, Liu J, Liu X, Chen
X, Li C and Zeng Y: p38γ overexpression in gliomas and its role in
proliferation and apoptosis. Sci Rep. 3:20892013. View Article : Google Scholar : PubMed/NCBI
|
42
|
Xu M, Wang S, Wang Y, Wu H, Frank JA,
Zhang Z and Luo J: Role of p38gamma MAPK in regulation of EMT and
cancer stem cells. Biochim Biophys Acta Mol Basis Dis.
1864:3605–3617. 2018. View Article : Google Scholar : PubMed/NCBI
|
43
|
Mao X, Xu J, Wang W, Liang C, Hua J, Liu
J, Zhang B, Meng Q, Yu X and Shi S: Crosstalk between
cancer-associated fibroblasts and immune cells in the tumor
microenvironment: New findings and future perspectives. Mol Cancer.
20:1312021. View Article : Google Scholar : PubMed/NCBI
|